Evidence map›Paper›PMID 41374952›Full record

ReviewCancers2025

The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment.

Balquees Kanwal, Syeda Saba Shah, Farzana Shaheen, Mekonnen Sisay Shiferaw, Deepanshu Maurya, Yujie Li, Saranya Pounraj, Zaklina Kovacevic

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Potential Role of Vitamin D inInternational journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Balquees KanwalAtta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), H-12, Islamabad 44000, Pakistan.ORCID 0000-0001-5464-3923
Syeda Saba ShahAtta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), H-12, Islamabad 44000, Pakistan.
Farzana ShaheenDepartment of Chemistry, Faculty of Science, Allama Iqbal Open University (AIOU), H-8/4 Campus, Islamabad 44310, Pakistan.
Mekonnen Sisay ShiferawSchool of Biomedical Sciences, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0001-6611-1174
Deepanshu MauryaSchool of Biomedical Sciences, University of New South Wales, Sydney 2052, Australia.
Yujie LiSchool of Biomedical Sciences, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0001-7597-9741
Saranya PounrajSchool of Biomedical Sciences, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0002-8165-6364
Zaklina KovacevicSchool of Biomedical Sciences, University of New South Wales, Sydney 2052, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intricate and diverse TME within breast cancer (BC) comprises a complex amalgamation of cell populations, encompassing immune cells, cancer-associated fibroblasts, cancer stem cells and the extracellular matrix. These constituents have profound influence over tumor progression and metastasis. Vitamin D (VD) is increasingly recognized as a multifunctional hormone, with strong clinical and epidemiological evidence supporting its protective role against cancer, particularly BC. Although its anti-neoplastic effects in BC have been widely studied, few investigations have thoroughly explored its influence within the tumor microenvironment (TME). This review seeks to address that gap by clarifying the current understanding of VD's regulatory functions in the TME of BC. The pivotal anti-cancer functions of VD comprise a spectrum of activities, influencing cell cycle regulation, chemoprotection, differentiation, apoptosis, proliferation, angiogenesis, as well as having anti-metastatic and anti-invasive properties. In this review, we comprehensively outline VD's anti-cancer mechanisms within the context of the BC TME, meticulously detailing its regulatory impact on cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix. This unique perspective highlights the potential of using VD to re-program the TME and enhance the efficacy of current BC therapeutics.

Indexed as

breast cancerfibroblaststumor microenvironmentvitamin D

Identifiers

PMID41374952
PMCPMC12691352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.